|
|
| ÂÒá¡éËÇÑ´ | 7 |  | 3.89 |
| ÂÒ | 4 | | 2.22 |
| ÈÙ¹ÂìÇԷºÃÔ¡Òà ËÁÒ¶֧ | 4 | | 2.22 |
| ËéͧÊÁØ´ã¹»ÃÐà·Èä·Â | 3 | | 1.67 |
| ÂҪش ËÁÒ¶֧ | 3 | | 1.67 |
| «Ù¤ÃÒâÅÊ | 3 | | 1.67 |
| á¡éä¢Â saccharin | 2 | | 1.11 |
| ÂÒʵÃÕºÑÇá¡éÇẺàÁç´ | 2 | | 1.11 |
| ͧ¤ì¡ÒÃÍÒËÒÃáÅÐÂÒ | 2 | | 1.11 |
| ¨Õ àÍçÁ ¾Õ âç¼ÅÔµ¹éÓá¢ç§ | 2 | | 1.11 |
| ¤ÙèÁ×Í¡ÒõÃǨʶҹ·Õè¼ÅÔµ¹éÓá¢ç§ | 2 | | 1.11 |
| ¼ÔÇ¢ÒÇ¢Öé¹ áººªÁ¾Ù¹Øª ¡ÅÔè¹¨Ó»Ò | 2 | | 1.11 |
| ÇÔà¤ÃÒÐËìÍØ»ÊÃä¢Í§¡ÒúԹä·Â | 2 | | 1.11 |
| ¤ÙèÁ×Í¡ÒÃáÊ´§©ÅÒ¡Áҵðҹ¢Í§ÍÒËÒáÅØèÁ 3 | 2 | | 1.11 |
| ¢éÍ¡Ó˹´ ÍÒËÒà ÍÂ. | 2 | | 1.11 |
| àÍ¡ÊÒÃÊØ¢ÀÒ¾¶éǹ˹éÒ30 | 2 | | 1.11 |
| ¤ÃÕÁÁÔÊà´Âì | 2 | | 1.11 |
| ˹ѧÊ×ͤÃͺ¤ÃÑÇÍÅǹ¤¹ÍÅàǧ | 2 | | 1.11 |
| áªÁ¾ÙÊѵÇì Çѵ¶ØÖÍѹµÃÒ Í | 2 | | 1.11 |
| Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ | 2 | | 1.11 |
| «Ùâ´ÍÕà¿´ÃÕ¹ | 2 | | 1.11 |
| ˹ѧÊ×ÍãËÁè | 2 | | 1.11 |
| µÑÇÍÂèÒ§¢Í§¡ÒõÃǨµÔÁµÒÁ¢Í§¡ÒüÅÔµäÊé¡ÃÍ¡ | 2 | | 1.11 |
| ÂÒá¡éä¢éËÇÑ´ | 2 | | 1.11 |
| ¡ÒäԴàªÔ§Ãкº systematic approach | 2 | | 1.11 |
| ¤Ó¢ÇѼÅÔµÀѳ±ìÊØ¢ÀÒ¾ | 1 | | 0.56 |
| ÂÒ¨Õ¹à¾ÔèÁÊÁÃöÀÒ¾·Ò§à¾È | 1 | | 0.56 |
| ¡Í§¤Çº¤ØÁÍÒËÒà | 1 | | 0.56 |
| à´Ô¹àÃ×èͧ Í. | 1 | | 0.56 |
| ¼Ùé¹ÓÊ»ÍÃìµµÃ͹ | 1 | | 0.56 |
| ÂÒʵÃÕÊÔ§àË | 1 | | 0.56 |
| ÂÒªÒlocal anesthetics | 1 | | 0.56 |
| g8injv'levk',b | 1 | | 0.56 |
| §Ò¹ÇԨѻٹà¤ÕéÂÇËÁÒ¡¡Ó¨Ñ´ÅÙ¡¹éÓ | 1 | | 0.56 |
| ä´ÂÒâÁâµÐ àÂÅÅÕè | 1 | | 0.56 |
| ºéÒ¹ÊѹµÔÊØ¢ ÍíÒàÀÍ˹ͧãËè ¨Ñ§ËÇÑ´ªÅºØÃÕ | 1 | | 0.56 |
| legano blonder bleaching áÅмÅÔµÀѳ±ìà»ÅÕè¹ÊÕ¼ÔÇáÅТ¹¼ÊÁÁТÒÁ | 1 | | 0.56 |
| ¡®¡ÃзÃǧ ¾ÃÐÃÒªºÑѵÔÍÒËÒà »ÃСÒÈ¡ÃзÃǧÊÒ¸ÒóÊØ¢ | 1 | | 0.56 |
| ËÒ«×éÍephedrine | 1 | | 0.56 |
| ¡Òâ͢Öé¹·ÐàºÕ¹ Í ÂÒ»ÅÇ¡ | 1 | | 0.56 |
| ÂÒ ÊµÃÕ ¹Ô ÊÔ§ àË | 1 | | 0.56 |
| ¢éÍÁÙżÅÔµÀѳ±ìà¾×èÍÊØ¢ÀÒ¾ | 1 | | 0.56 |
| âËÂè§àËÔ§ ËÅÍ¡Åǧ | 1 | | 0.56 |
| ¤ÙèÁ×Í¡ÒÃáÊ´§©ÅÒ¡Áҵðҹ¢Í§ÍÒËÒáÅØèÁ 1 | 1 | | 0.56 |
| ÇÔ¸Õ¡ÒáÓ˹´¢¹Ò´¢Í§¤ÇÒÁ¨Øharddisk | 1 | | 0.56 |
| ÊØ¢ÀÒ¾¼ÙéºÃÔâÀ¤ | 1 | | 0.56 |
| ¡ÒÃà¡çºà¹×éÍËÁÙ µÙéàÂç¹ | 1 | | 0.56 |
| powerpoint ÂÒàʾµÔ´ ¸íÒÃÑ¡Éì | 1 | | 0.56 |
| «ÙµÃÒâÅÊ | 1 | | 0.56 |
| elib fda | 1 | | 0.56 |
| ÂÒÇÒ¿ÒÃÔ¹ | 1 | | 0.56 |
| ¹éÓÁѹ¨ÁÙ¡¢éÒÇâ¦É³ÒªÇ¹àª×èÍ | 1 | | 0.56 |
| ÇÔà¤ÃÒÐËì¡ÒúԹä·Â | 1 | | 0.56 |
| ÂÒ¿Õ¹ÔÅâ»Ã»Òâ¹ÅÒÁÕ¹ | 1 | | 0.56 |
| ºÒÃìâ¤é´ÍÒËÒÃààÅÐÂÒ | 1 | | 0.56 |
| aspirin ¡Åä¡¡ÒÃÍÍ¡Ä·¸Ôì | 1 | | 0.56 |
| ¤´Õ¡®ËÁÒÂà¤Ã×èͧÊÓÍÒ§ | 1 | | 0.56 |
| à¤Ã×èͧÊÓÍÒ§ÊÓà¾ç§ | 1 | | 0.56 |
| ªÕǨԵ ¡ÒÃãªéªÕÇÔµÍÂèÒ§à¢éÒ㨸ÃÃÁªÒµÔ ÂèÍ | 1 | | 0.56 |
| ¤ÙèÁ×Í ËÅѡࡳ±ì ÂÒãËÁè new drug Í Â | 1 | | 0.56 |
| á¼¹ÀÙÁÔáÊ´§á¹Çâ¹éÁ¸ØáԨÃéÒ¹ÍÒËÒà | 1 | | 0.56 |
| »ÃСÒÈ ÍÂ. pseudoephedrine | 1 | | 0.56 |
| ÍÒ¡Ò÷ҧ¨Ôµ ÊÒû¹à»×é͹ | 1 | | 0.56 |
| â¦É³Ò ¼ÅÔµÀѳ±ìàÊÃÔÁÍÒËÒà µèÒ§»ÃÐà·È | 1 | | 0.56 |
| ÂÔ¹´Õà¹à¨ÍÃìâ»Ã´Ñ¡Êì | 1 | | 0.56 |
| ÇÔà¤ÃÒÐËì ¡ÒúԹä·Â | 1 | | 0.56 |
| ÂÒá¡éä¢éËÇÑ´ãËè | 1 | | 0.56 |
| ÇÔ¸Õ¡ÒÃãªéËéͧÊÁØ´ | 1 | | 0.56 |
| ÂÒµéÒ¹¡ÒÃÍÑ¡àʺ·ÕèäÁèãªènsiad | 1 | | 0.56 |
| ËÂÍ´ÂÒÊàµÕÂÃÍ´ì¤ÃÑé§à´ÕÂÇáÅéÇËÂØ´ | 1 | | 0.56 |
| ¾ÄµÔ¡ÃÃÁ¡ÒúÃÔâÀ¤¼ÅÔµÀѳ±ìÊØ¢ÀÒ¾¢Í§»ÃЪҪ¹¨Ñ§ËÇÑ´»ÑµµÒ¹Õ »Õ 2550 | 1 | | 0.56 |
| ÂÒ calypsol | 1 | | 0.56 |
| ¾.ª¹ÔµÇìÇѳ³ì µÃÕÇÔ·ÂÒÀÙÁÔ | 1 | | 0.56 |
| Êíҹѡ§Ò¹ÍÒËÒÃáÅÐÂÒ á¼¹·Õè | 1 | | 0.56 |
| µÓÊÑè§Êӹѡ§Ò¹ÍÒËÒÃáÅÐÂÒ ©ºÑº·Õè 398/2544 | 1 | | 0.56 |
| rh1 | 1 | | 0.56 |
| ÅÕ¨ÕâÍà¹ÅÒ | 1 | | 0.56 |
| µÓÂÒ¹ | 1 | | 0.56 |
| âäÃéÒ¤ÃèÒ » 1 »Ô´¡Ãا෾¤ÃÔÊàµÕ¹ | 1 | | 0.56 |
| ¢èÒÇ ÍѹµÃÒ¨ҡàÊ鹡 | 1 | | 0.56 |
| ¤ÅÔ¹Ô¡áÅçºàÍ¡ª¹·ÕèÁÑºÑªÕ | 1 | | 0.56 |
| ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ naltrexone | 1 | | 0.56 |
| µÔ´ÂÒâ«áÅÁÁÕÍÒ¡Òà | 1 | | 0.56 |
| ÂÒÇÒÃì¿ÒÃÔ¹ | 1 | | 0.56 |
| ªÁ¾Ùè ¡è͹ºèÒ ¼ÔÇ¢ÒÇ | 1 | | 0.56 |
| ¡ÅØèÁྐྵ¹Ô«ÔÅÅÔ¹ | 1 | | 0.56 |
| ÊÃþ¤Ø³ÂÒૺä·Í⫹ | 1 | | 0.56 |
| Êíҹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ à¤Ã×èͧÊíÒÍÒ§ | 1 | | 0.56 |
| «×éÍàÅÔ¿âŪÑè¹ä´é·Õè | 1 | | 0.56 |
| ÅÙ¡ªÔé¹¹ÒÂÎÑè§ | 1 | | 0.56 |
| free sale certificate + à¾×èÍ¡ÒÃÊè§ÍÍ¡ | 1 | | 0.56 |
| ¡ÒÃà»ÅÕè¹µÑǼÙéÃѺÁͺÍÓ¹Ò¨¢Í§ ¡ÅØèÁ¤Çº¤ØÁà¤Ã×èͧÊÓÍÒ§ | 1 | | 0.56 |
| Êٵà ¡ÃÐà¾ÒлÅÒµØë¹ ÂÒ¨Õ¹ | 1 | | 0.56 |
| ½Ñ§à¢çÁ¿ÃÕ ÁÙŹԸԵ§ÎÑéÇ | 1 | | 0.56 |
| ÇÔà¤ÃÒÐËì swot ¡ÒúԹä·Â | 1 | | 0.56 |
| ÂÒÅÐÅÒÂÅÔèÁàÅ×Í´ | 1 | | 0.56 |
| ÇÔ¸Õ·Ó¡ÃÐà¾ÒлÅÒµØë¹ÂÒ¨Õ¹ | 1 | | 0.56 |
| ÇÔ¸Õ ¡Òà ·Ó ªÒ ÊÁعä¾Ã | 1 | | 0.56 |
| ¼Ñ§javac.exe | 1 | | 0.56 |
| ¡Ò÷ÓÅÒ ËÁ´ÍÒÂØ ÍÂ. | 1 | | 0.56 |
,
User's Guide
˹éÒÅçÍ¡ÍÔ¹| ʶԵÔÃÒ»Õ
| ʶԵÔÃÒÂà´×͹
| ʶԵÔÃÒÂÇѹ
| ʶԵÔÃÒªÑèÇâÁ§
| Eng
Pageview 
Unique IPs 
Sessions